Month: December 2022

December 31, 2022December 31, 2022

Amelanotic conjunctival melanoma in a child.

Melanoma Literature

Publication date: Mar 01, 2023 Malignant melanomas of the conjunctiva are extremely rare in children. In this case report we present a conjunctival melanoma of a child. We report a ... Read more

December 31, 2022December 31, 2022

Lymph protects metastasizing melanoma cells from ferroptosis

Melanoma Media

December 31, 2022December 31, 2022

Ask the Doctor – Dr. Nigel Symss, Neurosurgeon

Parkinson's Disease Media

December 31, 2022December 31, 2022

A Phase 1/2 Study of Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab Following Stereotactic Radiosurgery in Patients With Melanoma Brain Metastases

Melanoma News

Publication date: Dec 30, 2022 This phase I/II trial will investigate the use of the novel oral IRAK-4 inhibitor CA-4948 in combination with pembrolizumab therapy following stereotactic radiosurgery in patients ... Read more

December 31, 2022December 31, 2022

A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and in Combination With Trametinib in Subjects With BRAF V600 Mutant Solid Tumors

Melanoma News

Publication date: Dec 30, 2022 The purpose of this study is to evaluate the safety and tolerability of CFT1946 as well as to determine the maximum tolerated dose (MTD) and/or ... Read more

December 31, 2022December 31, 2022

Cancer Vaccine Hunt Makes Progress, Finally

Melanoma News

Publication date: Dec 31, 2022 Bauman led an earlier study of Modernas cancer vaccine. The study enrolled melanoma patients who had undergone surgery to remove any signs of their cancer. ... Read more

December 31, 2022December 31, 2022

Ask the Experts: Understanding and Recognizing Dystonia in Parkinson’s Disease

Parkinson's Disease Media

December 31, 2022December 31, 2022

Tech helps track Parkinson’s symptoms to help patients live better lives

Parkinson's Disease Media

https://www.youtube.com/watch?v=fsVhRaWhKS0

December 31, 2022December 31, 2022

Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Metastatic Cancer Survivors Treated With Immunotherapy, Followed by an Integrative Neurocognitive Remediation Therapy Program

Melanoma News

Publication date: Dec 29, 2022 Since 2010, the field of immunotherapy has grown substantially, leading to a growing population of long-term cancer survivors treated with immunotherapy. Since cancer survivorship in ... Read more

December 30, 2022December 30, 2022

Expression and clinical significance of TYRP1, ABCB5, and MMP17 in sinonasal mucosal melanoma.

Melanoma Literature

Publication date: Nov 15, 2022 Sinonasal mucosal melanoma (SNMM) is a lethal malignancy with poor prognosis. Treatment outcomes of SNMM are poor. Novel prognostic or progression markers are needed to ... Read more